Revefenacin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Revefenacin. Educational only — not medical advice.
Labeled uses
YUPELRI is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Source: FDA labeling via NIH DailyMed (set 6dfebf04…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.